Search results
Results From The WOW.Com Content Network
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations , biopharmaceuticals , nutrition products, vaccines and active pharmaceutical ingredients (APIs). [ 4 ]
Habil Khorakiwala is the founder and Chairman of Indian multinational pharmaceutical and biotechnology company Wockhardt. [1] He founded Wockhardt in 1967, [2] which since then has grown into one of the top Indian makers of generic drugs, formulations, biopharmaceuticals, nutrition products, vaccines, active pharmaceutical ingredients (APIs) and a chain of advanced Super Speciality Hospitals.
Wockhardt Hospitals Ltd is an Indian for-profit private hospital network headquartered in Mumbai. [4] The chain of hospitals is owned by the promoters of Wockhardt , [ 5 ] a multinational pharmaceutical company. [ 6 ]
Fakhruddin T. Khorakiwala was an Indian businessman and Sheriff of Mumbai.From 2000 until his death, he was the chancellor of Jamia Millia Islamia. [2] He was a well-known Indian businessman, and founded the Akbarallys group of departmental stores in Mumbai.
Torrent Pharmaceuticals was established in 1959 by U. N. Mehta as Trinity Laboratories. It was renamed as Torrent Pharmaceuticals in 1971. [5]In 1997, Torrent Pharma and Sanofi established a 50:50 joint venture called Sanofi Torrent for selling Torrent Pharma's products. [6]
CSC partners with Fortis Hospital to launch telemedicine service for rural India, Feb 21. [21] Fortis Healthcare partners with RED.Health to provide ambulances in 10-30 minutes, June 23. [22] Fortis Bannerghatta Road joins hands with JOGO Health, to provide non-surgical, tech-driven treatment for urinary disorders, Dec 23. [23]
The hospitals trace their origins to the Kasturba Medical College, founded by T. M. A. Pai in 1953. [7] Manipal Hospitals is the second largest healthcare provider in India, [8] with a network of 33 hospitals. [1] Manipal Hospitals is part of the Manipal Education and Medical Group. [9]
The company's first international move took it to Russia in 1992. There, Dr. Reddy's formed a joint venture with the country's biggest pharmaceuticals producer, Biomed.They pulled out in 1995 amid accusations of scandal, involving "a significant material loss due to the activities of Moscow's branch of Reddy's Labs with the help of Biomed's chief executive". [8]